In this regard, although EGF (5ppm) did not show a better effect than EGF (1ppm) treatment on PAR-2 and TSLP expression, our findings indicate that EGF can ameliorate itching as well as the immune response by inhibiting PAR-2 and TSLP expression in AD lesions. This evidence concerns the gene F2RL1 and Alzheimer disease.